Patrick S. Johnson

3.6k total citations
71 papers, 2.4k citations indexed

About

Patrick S. Johnson is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Organic Chemistry. According to data from OpenAlex, Patrick S. Johnson has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 12 papers in Clinical Psychology and 10 papers in Organic Chemistry. Recurrent topics in Patrick S. Johnson's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Decision-Making and Behavioral Economics (10 papers) and Adolescent Sexual and Reproductive Health (9 papers). Patrick S. Johnson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Decision-Making and Behavioral Economics (10 papers) and Adolescent Sexual and Reproductive Health (9 papers). Patrick S. Johnson collaborates with scholars based in United States, United Kingdom and France. Patrick S. Johnson's co-authors include Matthew W. Johnson, Gregory J. Madden, Evan S. Herrmann, Mary M. Sweeney, Nancy M. Petry, J A Mailliard, Olga Rass, Lauren R. Pacek, Larry P. Ebbert and Roland R. Griffiths and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Patrick S. Johnson

71 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick S. Johnson United States	25	535	406	386	341	305	71	2.4k
Geert Dom Belgium	40	258 0.5×	1.0k 2.6×	1.1k 2.8×	360 1.1×	249 0.8×	165	4.9k
Laura MacPherson United States	37	239 0.4×	1.6k 4.0×	368 1.0×	754 2.2×	588 1.9×	104	3.6k
Michael Stefanek United States	34	1.7k 3.1×	445 1.1×	181 0.5×	287 0.8×	141 0.5×	77	4.1k
Benjamin A. Toll United States	37	705 1.3×	355 0.9×	445 1.2×	1.1k 3.2×	2.5k 8.3×	157	4.4k
Caryn Lerman United States	53	2.4k 4.5×	358 0.9×	1.2k 3.0×	620 1.8×	886 2.9×	94	8.2k
Janet Audrain United States	32	296 0.6×	394 1.0×	969 2.5×	490 1.4×	1.5k 4.9×	41	3.1k
Ruiyang Wu United States	32	84 0.2×	703 1.7×	582 1.5×	320 0.9×	739 2.4×	105	3.0k
Suzanne C. O’Neill United States	24	522 1.0×	354 0.9×	191 0.5×	172 0.5×	206 0.7×	98	2.1k
David T. Zava United States	35	581 1.1×	195 0.5×	1.0k 2.6×	43 0.1×	124 0.4×	86	4.0k
Lisa Sanderson Cox United States	30	473 0.9×	291 0.7×	840 2.2×	824 2.4×	2.4k 8.0×	102	3.7k

Countries citing papers authored by Patrick S. Johnson

Since Specialization

Citations

This map shows the geographic impact of Patrick S. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick S. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick S. Johnson more than expected).

Fields of papers citing papers by Patrick S. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick S. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick S. Johnson. The network helps show where Patrick S. Johnson may publish in the future.

Co-authorship network of co-authors of Patrick S. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick S. Johnson. A scholar is included among the top collaborators of Patrick S. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick S. Johnson. Patrick S. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berry, Meredith S., Gideon P. Naudé, Patrick S. Johnson, & Matthew W. Johnson. (2023). The Blinded-Dose Purchase Task: assessing hypothetical demand based on cocaine, methamphetamine, and alcohol administration. Psychopharmacology. 240(4). 921–933. 3 indexed citations

Berry, Meredith S., Mary M. Sweeney, Sean B. Dolan, et al.. (2020). Attention-Deficit/Hyperactivity Disorder Symptoms Are Associated with Greater Delay Discounting of Condom-Protected Sex and Money. Archives of Sexual Behavior. 50(1). 191–204. 7 indexed citations

Johnson, Patrick S., Mary M. Sweeney, Evan S. Herrmann, & Matthew W. Johnson. (2016). Alcohol Increases Delay and Probability Discounting of Condom‐Protected Sex: A Novel Vector for Alcohol‐Related HIV Transmission. Alcoholism Clinical and Experimental Research. 40(6). 1339–1350. 47 indexed citations

Sweeney, Mary M., Olga Rass, Patrick S. Johnson, et al.. (2016). Initial feasibility and validity of a prospective memory training program in a substance use treatment population.. Experimental and Clinical Psychopharmacology. 24(5). 390–399. 4 indexed citations

Meredith, Steven E., Mary M. Sweeney, Patrick S. Johnson, Matthew W. Johnson, & Roland R. Griffiths. (2015). Weekly Energy Drink Use Is Positively Associated with Delay Discounting and Risk Behavior in a Nationwide Sample of Young Adults. PubMed. 6(1). 10–19. 24 indexed citations

Herrmann, Evan S., Patrick S. Johnson, & Matthew W. Johnson. (2015). Examining Delay Discounting of Condom-Protected Sex Among Men Who Have Sex with Men Using Crowdsourcing Technology. AIDS and Behavior. 19(9). 1655–1665. 37 indexed citations

Rass, Olga, Lauren R. Pacek, Patrick S. Johnson, & Matthew W. Johnson. (2015). Characterizing use patterns and perceptions of relative harm in dual users of electronic and tobacco cigarettes.. Experimental and Clinical Psychopharmacology. 23(6). 494–503. 92 indexed citations

Johnson, Matthew W., Natalie R. Bruner, & Patrick S. Johnson. (2014). Cocaine dependent individuals discount future rewards more than future losses for both cocaine and monetary outcomes. Addictive Behaviors. 40. 132–136. 18 indexed citations

Vandrey, Ryan G., et al.. (2013). Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace. Adolescent Psychiatry. 3(2). 123–134. 21 indexed citations

10.

Johnson, Patrick S., Thomas Ryckmans, Justin S. Bryans, et al.. (2011). Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability. Bioorganic & Medicinal Chemistry Letters. 21(19). 5684–5687. 13 indexed citations

11.

Dack, Kevin N., S. Skerratt, Patrick S. Johnson, Paul A. Bradley, & Ian R. Marsh. (2010). Optimisation of a pyrazole series of progesterone antagonists; Part 1. Bioorganic & Medicinal Chemistry Letters. 20(11). 3384–3386. 3 indexed citations

12.

Madden, Gregory J., Nancy M. Petry, & Patrick S. Johnson. (2009). Pathological gamblers discount probabilistic rewards less steeply than matched controls.. Experimental and Clinical Psychopharmacology. 17(5). 283–290. 148 indexed citations

13.

Beal, David M., David Ellis, David W. Gordon, et al.. (2008). Acid-Mediated Synthesis of 3-N,N-Dialkyl-amino-1,2,4-Triazoles. Synfacts. 2008(12). 1263–1263. 1 indexed citations

14.

Middleton, Donald S., Mark D. Andrews, Paul A. Glossop, et al.. (2008). Designing rapid onset selective serotonin re-uptake inhibitors. 2: Structure–activity relationships of substituted (aryl)benzylamines. Bioorganic & Medicinal Chemistry Letters. 18(14). 4018–4021. 8 indexed citations

15.

Webster, Robert O., et al.. (1998). Microbial oxidative metabolism of diclofenac: production of 4′-hydroxydiclofenac using Epiccocum nigrum IMI354292. Applied Microbiology and Biotechnology. 49(4). 371–376. 39 indexed citations

16.

Hartmann, Lynn C., Loren K. Tschetter, Thomas M. Habermann, et al.. (1997). Granulocyte Colony-Stimulating Factor in Severe Chemotherapy-Induced Afebrile Neutropenia. New England Journal of Medicine. 336(25). 1776–1780. 126 indexed citations

17.

Blagg, Julian, Stephen A. Ballard, Kelvin Cooper, et al.. (1996). The development of non-steroidal dual inhibitors of both human 5α-reductase isozymes. Bioorganic & Medicinal Chemistry Letters. 6(13). 1517–1522. 9 indexed citations

18.

Creagan, Edward T., Donald I. Twito, Daniel J. Schaid, et al.. (1991). A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenocarcinoma.. Journal of Clinical Oncology. 9(12). 2104–2109. 42 indexed citations

19.

Loprinzi, Charles L., Neil M. Ellison, Daniel J. Schaid, et al.. (1990). Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia. JNCI Journal of the National Cancer Institute. 82(13). 1127–1132. 234 indexed citations

20.

Albano, William A., Michael Dürr, James A. Mailliard, et al.. (1984). Hepatic Artery Infusion: Surgical Approach. PubMed. 1(3). 213–226. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact